AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12790216 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (M, MM, MK)
Number of subjects: 90
Study 10375052 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 kcal/d very low calorie diet (VLCD) for 5 days
Number of subjects: 20
Study 10375052 — intervention group
Group type: EXPERIMENTAL
Intervention: 900 kcal/d low calorie diet (LCD) for 6 months
Number of subjects: 20
Study 8876886 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-cm margin
Number of subjects: 742
Study 8876886 — intervention group
Group type: COMPARATOR
Intervention: 4-cm margin
Number of subjects: 742
Study 8876886 — intervention group
Group type: EXPERIMENTAL
Intervention: Thickness of primary lesion
Number of subjects: 742
Study 8876886 — intervention group
Group type: EXPERIMENTAL
Intervention: Ulceration of primary lesion
Number of subjects: 742
Study 2062330 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma exchange
Number of subjects: 102
Study 2062330 — intervention group
Group type: COMPARATOR
Intervention: Plasma infusion
Number of subjects: 102
Study 6192139 — intervention group
Group type: EXPERIMENTAL
Intervention: High dosage regimen (group A) - MMI: 60 +/- 14.5 mg/day or PTU: 693 +/- 173 mg/day, with T3 addition.
Number of subjects: 113
Study 6192139 — intervention group
Group type: COMPARATOR
Intervention: Low dosage regimen (group B) - MMI: 13.6 +/- 7 mg/day or PTU: 180 +/- 58 mg/day, without T3 addition.
Number of subjects: 113
Study 30624373 — intervention group
Group type: EXPERIMENTAL
Intervention: Pursed Lip Breathing (PLB)
Number of subjects: 35
Study 30624373 — intervention group
Group type: COMPARATOR
Intervention: Usual breathing
Number of subjects: 35
Study 28760461 — intervention group
Group type: EXPERIMENTAL
Intervention: Added dead space (aDS) during mild exercise
Number of subjects: 10
Study 28760461 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild exercise
Number of subjects: 10
Study 28760461 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxia
Number of subjects: 10
Study 28760461 — intervention group
Group type: COMPARATOR
Intervention: Control (no added dead space)
Number of subjects: 10
Study 24866854 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance Facilitating Intervention (short informational video)
Number of subjects: 104
Study 24866854 — intervention group
Group type: COMPARATOR
Intervention: No-intervention Control Group (CG)
Number of subjects: 104
Study 24075228 — intervention group
Group type: EXPERIMENTAL
Intervention: Cultured allogeneic fibroblasts in a crystalloid suspension solution with 2% albumin
Number of subjects: 0
Study 24075228 — intervention group
Group type: COMPARATOR
Intervention: Suspension solution alone
Number of subjects: 0
Study 24075228 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (fibroblasts and suspension solution)
Number of subjects: 0
Study 21666590 — intervention group
Group type: EXPERIMENTAL
Intervention: Nakom (levodopa and carbidopa)
Number of subjects: 0
Study 21666590 — intervention group
Group type: COMPARATOR
Intervention: Tidomed (levodopa and carbidopa)
Number of subjects: 0
Study 19571078 — intervention group
Group type: EXPERIMENTAL
Intervention: Locked volar plate
Number of subjects: 46
Study 19571078 — intervention group
Group type: COMPARATOR
Intervention: Augmented external fixation
Number of subjects: 46
Study 19571078 — intervention group
Group type: COMPARATOR
Intervention: Locked radial column plate
Number of subjects: 46
Study 16863598 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive functioning assessed 6 weeks after surgery
Number of subjects: 291
Study 16863598 — intervention group
Group type: EXPERIMENTAL
Intervention: Fear of falling assessed 6 weeks after surgery
Number of subjects: 291
Study 16863598 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain assessed within 2 weeks after surgery
Number of subjects: 291
Study 16863598 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressive symptoms assessed within 2 weeks after surgery
Number of subjects: 291
Study 14769578 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway
Number of subjects: 34
Study 14769578 — intervention group
Group type: COMPARATOR
Intervention: Subarachnoid block
Number of subjects: 34
Study 14769578 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 34
Study 11840725 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical practice guidelines (CPGs)
Number of subjects: 0
Study 11840725 — intervention group
Group type: EXPERIMENTAL
Intervention: Guidelines that passed the appraisal process
Number of subjects: 0
Study 11840725 — intervention group
Group type: EXPERIMENTAL
Intervention: Guidelines for guideline development by the Scottish Intercollegiate Guideline Network
Number of subjects: 0
Study 11840725 — intervention group
Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study 9491016 — intervention group
Group type: EXPERIMENTAL
Intervention: Gimme‐5 program with teacher wellness program (54 workshops over 2 years)
Number of subjects: 32
Study 9491016 — intervention group
Group type: COMPARATOR
Intervention: Gimme‐5 program (comparison group)
Number of subjects: 32
Study 8153578 — intervention group
Group type: EXPERIMENTAL
Intervention: Triclosan in polyethylene glycol
Number of subjects: 8
Study 8153578 — intervention group
Group type: EXPERIMENTAL
Intervention: Triclosan in glycerol
Number of subjects: 8
Study 8153578 — intervention group
Group type: EXPERIMENTAL
Intervention: Triclosan in 3% sodium lauryl sulfate (SLS)
Number of subjects: 8
Study 8153578 — intervention group
Group type: EXPERIMENTAL
Intervention: Triclosan in Tween 80
Number of subjects: 8
Study 2971565 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled salbutamol
Number of subjects: 13
Study 2971565 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled ipratropium bromide
Number of subjects: 13
Study 2971565 — intervention group
Group type: EXPERIMENTAL
Intervention: Perfusion of aminophylline
Number of subjects: 13
Study 2971565 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of bronchodilators
Number of subjects: 13
Study 31622386 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized Speed of Processing Training (SOPT)
Number of subjects: 351
Study 31622386 — intervention group
Group type: COMPARATOR
Intervention: Computerized crossword puzzles (control)
Number of subjects: 351
Study 29171497 — intervention group
Group type: EXPERIMENTAL
Intervention: mCIMT
Number of subjects: 88
Study 29171497 — intervention group
Group type: EXPERIMENTAL
Intervention: touch glove
Number of subjects: 88
Study 29171497 — intervention group
Group type: COMPARATOR
Intervention: control group
Number of subjects: 88
Study 26218883 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental Group (EG) - myofascial induction technique added to a multimodal protocol including neuromuscular technique over the masseter muscles and passive hamstring muscle stretching.
Number of subjects: 60
Study 26218883 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG) - neuromuscular technique over the masseter muscles and passive hamstring muscle stretching.
Number of subjects: 60
Study 23403474 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral citicoline 500 mg twice a day
Number of subjects: 349
Study 23403474 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 349
Study 22122817 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan 32 mg and HCT 25 mg
Number of subjects: 53
Study 22122817 — intervention group
Group type: COMPARATOR
Intervention: Candesartan 32 mg
Number of subjects: 53
Study 22122817 — intervention group
Group type: COMPARATOR
Intervention: HCT 25 mg
Number of subjects: 53
Study 19593887 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraarticular + subacromial injection
Number of subjects: 120
Study 19593887 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraarticular injection
Number of subjects: 120
Study 19593887 — intervention group
Group type: EXPERIMENTAL
Intervention: Subacromial injection
Number of subjects: 120
Study 19593887 — intervention group
Group type: EXPERIMENTAL
Intervention: Interscalenic brachial plexus block (IBPB)
Number of subjects: 120
Study 19593887 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study 17047178 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrison Pack (1-L enteral feeding system)
Number of subjects: 207
Study 17047178 — intervention group
Group type: COMPARATOR
Intervention: Glass bottle system (0.5-L)
Number of subjects: 207
Study 17047178 — intervention group
Group type: EXPERIMENTAL
Intervention: Delivery sets
Number of subjects: 207
Study 12923727 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin antagonists, lifestyle changes, and appropriate drugs to reduce cardiovascular risk factors
Number of subjects: 0
Study 12923727 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunosuppressive therapies (corticosteroids, cyclosporine, mycophenolate, cyclophosphamide)
Number of subjects: 0
Study 12923727 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study 10839912 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural morphine
Number of subjects: 0
Study 10839912 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous low-dose ketamine
Number of subjects: 0
Study 10839912 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of epidural morphine and intravenous ketamine
Number of subjects: 0
Study 9282292 — intervention group
Group type: EXPERIMENTAL
Intervention: Transurethral electrovaporization of the prostate (TUV-P)
Number of subjects: 27
Study 9282292 — intervention group
Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TUR-P)
Number of subjects: 27
Study 9282292 — intervention group
Group type: EXPERIMENTAL
Intervention: Transurethral electrovaporization of the prostate (TUV-P) (roller bar)
Number of subjects: 27
Study 9282292 — intervention group
Group type: EXPERIMENTAL
Intervention: Transurethral electrovaporization of the prostate (TUV-P) (roller loop)
Number of subjects: 27
Study 8359644 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% oleic acid
Number of subjects: 7
Study 8359644 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% oleic acid
Number of subjects: 7
Study 8359644 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 7
Study 3730737 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral prednisolone
Number of subjects: 40
Study 3730737 — intervention group
Group type: COMPARATOR
Intervention: No specific therapy (control)
Number of subjects: 40
Study 3730737 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (treated and control)
Number of subjects: 40
Study 30866027 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional counseling and medical therapy (treated)
Number of subjects: 457
Study 30866027 — intervention group
Group type: COMPARATOR
Intervention: Routine pregnancy management (untreated)
Number of subjects: 457
Study 29678193 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged grief-specific integrative cognitive behavioral therapy (PG-CBT)
Number of subjects: 204
Study 29678193 — intervention group
Group type: COMPARATOR
Intervention: Present-centered therapy (PCT)
Number of subjects: 204
Study 27174250 — intervention group
Group type: EXPERIMENTAL
Intervention: Health mindset
Number of subjects: 60
Study 27174250 — intervention group
Group type: COMPARATOR
Intervention: Palatability mindset
Number of subjects: 60
Study 24956865 — intervention group
Group type: EXPERIMENTAL
Intervention: Pingshen decoction 1 dose/d, bid po for 8 weeks
Number of subjects: 69
Study 24956865 — intervention group
Group type: COMPARATOR
Intervention: NephritisShu tablet, 6 tablets, tid po for 8 weeks
Number of subjects: 69
Study 24956865 — intervention group
Group type: COMPARATOR
Intervention: Healthy control group (30 cases)
Number of subjects: 69
Study 23356030 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose rifampicin (SDR) chemoprophylaxis
Number of subjects: 28092
Study 23356030 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 28092
Study 21269040 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3% triclosan, 2.0% PVM/MA copolymer, 0.243% sodium fluoride dentifrice
Number of subjects: 182
Study 21269040 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.454% stannous fluoride, sodium hexametaphosphate, zinc lactate dentifrice
Number of subjects: 182
Study 21269040 — intervention group
Group type: COMPARATOR
Intervention: 0.243% sodium fluoride dentifrice
Number of subjects: 182
Study 19011427 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (20 mg/d)
Number of subjects: 604
Study 19011427 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole (15 mg/d, increasing to 30 mg/d as needed)
Number of subjects: 604
Study 19011427 — intervention group
Group type: COMPARATOR
Intervention: Control (Lorazepam as needed, total dose ≤ 4 mg/d)
Number of subjects: 604
Study 16151977 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glulisine (0.3 U/kg)
Number of subjects: 18
Study 16151977 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin lispro (0.3 U/kg)
Number of subjects: 18
Study 16151977 — intervention group
Group type: COMPARATOR
Intervention: Regular human insulin (0.3 U/kg)
Number of subjects: 18
Study 12823705 — intervention group
Group type: EXPERIMENTAL
Intervention: Super‐EBA
Number of subjects: 81
Study 12823705 — intervention group
Group type: EXPERIMENTAL
Intervention: IRM
Number of subjects: 81
Study 12823705 — intervention group
Group type: EXPERIMENTAL
Intervention: ProRoot‐MTA
Number of subjects: 81
Study 12823705 — intervention group
Group type: COMPARATOR
Intervention: Finishing bur
Number of subjects: 81
Study 12823705 — intervention group
Group type: COMPARATOR
Intervention: Ball burnishing or Zekrya bur
Number of subjects: 81
Study 10999651 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol 8 mg [β‐2]
Number of subjects: 49
Study 10999651 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol 10 mg [mainly β‐2]
Number of subjects: 49
Study 10999651 — intervention group
Group type: EXPERIMENTAL
Intervention: Xamoterol 200 mg [β‐1]
Number of subjects: 49
Study 10999651 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 8604657 — intervention group
Group type: EXPERIMENTAL
Intervention: High-ketogenic VLED
Number of subjects: 13
Study 8604657 — intervention group
Group type: COMPARATOR
Intervention: Low-ketogenic VLED
Number of subjects: 13
Study 8136625 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose heparin (1 unit/ml) added to pre-mixed fluids
Number of subjects: 0
Study 8136625 — intervention group
Group type: COMPARATOR
Intervention: Standard fluids (control group)
Number of subjects: 0
Study 3304022 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency jet ventilation (HFJV)
Number of subjects: 7
Study 3304022 — intervention group
Group type: COMPARATOR
Intervention: Conventional mechanical ventilation (CV)
Number of subjects: 7
Study 29660858 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer counselling from trained community female volunteers starting in third trimester of pregnancy until 6 months after delivery
Number of subjects: 350
Study 29660858 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 350
Study 26906014 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (80 mg before surgery, 40 mg morning of surgery, 40 mg daily after surgery)
Number of subjects: 615
Study 26906014 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (80 mg morning of surgery, 40 mg morning after)
Number of subjects: 615
Study 26906014 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 615
Study 26502545 — intervention group
Group type: EXPERIMENTAL
Intervention: Red-hot needle therapy, treated with cauterized needles on specific acupuncture points, once every other day for 30 days.
Number of subjects: 80
Study 26502545 — intervention group
Group type: COMPARATOR
Intervention: Routine acupuncture, treated with filiform needles on specific acupuncture points, once daily for 30 days.
Number of subjects: 80
Study 23885607 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (electroacupuncture at Zusanli, Sanyinjiao, and Taichong for 30 min, once a day for 2 weeks)
Number of subjects: 40
Study 23885607 — intervention group
Group type: COMPARATOR
Intervention: Motilium (10 mg orally, three times a day for 2 weeks)
Number of subjects: 40
Study 20665738 — intervention group
Group type: EXPERIMENTAL
Intervention: Possible arthritis (chronic joint symptoms without doctor‐diagnosed arthritis)
Number of subjects: 2884
Study 18455211 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD4619
Number of subjects: 0
Study 18455211 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate
Number of subjects: 0
Study 18455211 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibric acid
Number of subjects: 0
Study 18455211 — intervention group
Group type: EXPERIMENTAL
Intervention: PPAR agonists
Number of subjects: 0
Study 17012045 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognostic index scoring based on age, sex, performance status, histological type, and TNM staging.
Number of subjects: 4479
Study 17012045 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognostic index scoring based on personal, tumour, and functional information.
Number of subjects: 4479
Study 15056067 — intervention group
Group type: EXPERIMENTAL
Intervention: Erbium: YAG Laser cataract extraction
Number of subjects: 0
Study 15056067 — intervention group
Group type: COMPARATOR
Intervention: Conventional cataract surgery
Number of subjects: 0
Study 11022053 — intervention group
Group type: COMPARATOR
Intervention: Plasma antioxidants (vitamin C, uric acid, vitamins A and E) and antioxidant enzyme activities (SOD and glutathione peroxidase) measured at various time points
Number of subjects: 38
Study 11022053 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A and uric acid plasma levels, erythrocyte SOD activity
Number of subjects: 38
Study 8540219 — intervention group
Group type: EXPERIMENTAL
Intervention: Denatonium benzoate (DB) at 30 ppm added to ethylene glycol and methanol
Number of subjects: 0
Study 8540219 — intervention group
Group type: COMPARATOR
Intervention: Ethylene glycol and methanol without DB
Number of subjects: 0
Study 2515973 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 micrograms levothyroxine day‐1 (group A)
Number of subjects: 166
Study 2515973 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 micrograms iodine day‐1 (group B)
Number of subjects: 166
Study 2515973 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 micrograms levothyroxine and 200 micrograms iodine day‐1 (group C)
Number of subjects: 166
Study 707973 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose combination type oral contraceptive
Number of subjects: 14
Study 707973 — intervention group
Group type: COMPARATOR
Intervention: d-norgestrel-releasing intrauterine device (d-Ng-IUD)
Number of subjects: 14
Study 31537812 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy (n=82)
Number of subjects: 158
Study 31537812 — intervention group
Group type: COMPARATOR
Intervention: No chemotherapy (n=76)
Number of subjects: 158
Study 31537812 — intervention group
Group type: EXPERIMENTAL
Intervention: Ki-67 assessment using method A (cut-off 10%)
Number of subjects: 158
Study 28750832 — intervention group
Group type: EXPERIMENTAL
Intervention: Working memory training (dual n-back) for six weeks
Number of subjects: 0
Study 28750832 — intervention group
Group type: COMPARATOR
Intervention: Processing speed training (active control)
Number of subjects: 0
Study 25165041 — intervention group
Group type: EXPERIMENTAL
Intervention: Eltrombopag 100 mg daily
Number of subjects: 26
Study 25165041 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 23648244 — intervention group
Group type: EXPERIMENTAL
Intervention: Domestic live attenuated hepatitis A vaccine (Group A)
Number of subjects: 493
Study 23648244 — intervention group
Group type: EXPERIMENTAL
Intervention: Domestic inactivated hepatitis A vaccine (Group B)
Number of subjects: 493
Study 23648244 — intervention group
Group type: EXPERIMENTAL
Intervention: Imported inactivated hepatitis A vaccine (Group C)
Number of subjects: 493
Study 23648244 — intervention group
Group type: COMPARATOR
Intervention: Hepatitis B vaccine (Group D)
Number of subjects: 493
Study 21645836 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinzaparin (100 IU/kg subcutaneously daily for 90 days) along with usual postoperative care
Number of subjects: 550
Study 21645836 — intervention group
Group type: COMPARATOR
Intervention: Usual postoperative care including chemotherapy when indicated
Number of subjects: 550
Study 19332468 — intervention group
Group type: EXPERIMENTAL
Intervention: Development of new ECG strain
Number of subjects: 7409
Study 19332468 — intervention group
Group type: EXPERIMENTAL
Intervention: Regression or persistence of ECG strain
Number of subjects: 7409
Study 19332468 — intervention group
Group type: COMPARATOR
Intervention: Absence of strain on both ECGs
Number of subjects: 7409
Study 16690550 — intervention group
Group type: EXPERIMENTAL
Intervention: Word Reading Test (WRT)
Number of subjects: 0
Study 16690550 — intervention group
Group type: COMPARATOR
Intervention: Word Memory Test (WMT)
Number of subjects: 0
Study 15492861 — intervention group
Group type: EXPERIMENTAL
Intervention: SPS (600 mg daily)
Number of subjects: 21
Study 15492861 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 11385165 — intervention group
Group type: EXPERIMENTAL
Intervention: Cutting Balloon angioplasty (CBA)
Number of subjects: 47
Study 11385165 — intervention group
Group type: COMPARATOR
Intervention: Conventional balloon angioplasty (PTCA)
Number of subjects: 47
Study 9207819 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg twice daily
Number of subjects: 20
Study 9207819 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine 150 mg once daily
Number of subjects: 20
Study 9207819 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 7820217 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin bolus 0.15-0.75 U/kg
Number of subjects: 60
Study 7820217 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin withdrawal and 3 days of intensive insulin therapy
Number of subjects: 60
Study 7820217 — intervention group
Group type: EXPERIMENTAL
Intervention: Arginine
Number of subjects: 60
Study 7820217 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal pancreatic polypeptide levels
Number of subjects: 60
Study 3124602 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepwise increase in daily dosage (1 to 4 g/kg) at a steady rate over 24 hours
Number of subjects: 45